BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast

  Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will report fourth quarter 2023 financial and operating results after market close on Wednesday, February 28, 2024.

  February 21, 2024

   · 

  1 min read
• Lone Star Bio

  Bio-Path Holdings Announces 1-for-20 Reverse Stock Split

  Bio-Path Holdings, Inc. announced that it intends to effect a reverse stock split of its outstanding common stock, par value $0.001 per share, at a ratio of 1-for-20.

  February 21, 2024

   · 

  5 min read
• Genetown

  Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events

  Editas Medicine, Inc. today announced that it will host a conference call and webcast on Wednesday, February 28, 2024, at 8:00 a.m. ET to discuss results for the fourth quarter and full year 2023 and to provide a corporate update.

  February 21, 2024

   · 

  2 min read
• Biotech Bay

  Gritstone bio to Participate in Upcoming Investor and Scientific Conferences

  Gritstone bio, Inc. today announced that management will be participating in the following investor and scientific conferences.

  February 21, 2024

   · 

  1 min read
• Genetown

  Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024

  Atea Pharmaceuticals, Inc. today announced that it will host a live conference call and audio webcast on Wednesday, February 28, 2024, at 4:30 p.m. ET to report financial results for the fourth quarter and full year ended December 31, 2023, and to provide a business update.

  February 21, 2024

   · 

  3 min read
• BioMidwest

  ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics

  ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, announced the successful initial use of its Artificial Intelligence program, named ADMAlytics.

  February 21, 2024

   · 

  5 min read
• Innate Pharma Announces Its Participation to Upcoming March 2024 Investor Conference

  Innate Pharma SA announced that members of its senior management team are scheduled to participate in the upcoming investor conference, detailed below.

  February 21, 2024

   · 

  3 min read
• Biotech Bay

  Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv

  Coherus BioSciences, Inc. today announced the launch of UDENYCA ONBODY™, the company’s on-body injector (OBI) presentation of UDENYCA ® (pegfilgrastim-cbqv).

  February 21, 2024

   · 

  10 min read
• Business

  ChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024

  ChromaDex Corp. announced that it will hold a conference call on Wednesday, March 6, 2024 at 4:30 p.m. ET to discuss its financial results for the fourth quarter, which ended December 31, 2023.

  February 21, 2024

   · 

  4 min read
• Business

  Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results

  Sarepta Therapeutics, Inc. will report fourth quarter and full-year 2023 financial results after the Nasdaq Global Market closes on Wednesday, Feb. 28, 2024.

  February 21, 2024

   · 

  1 min read